603939 益丰药房
2025/03 - 三个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)4.10314.89115.38315.73913.830
总资产报酬率 ROA (%)1.6125.8676.2526.6265.484
投入资产回报率 ROIC (%)1.8947.0107.6117.9956.469

边际利润分析
销售毛利率 (%)39.63840.12038.20939.52940.346
营业利润率 (%)10.8269.1599.0979.4828.736
息税前利润/营业总收入 (%)11.4689.7939.4029.9689.479
净利润/营业总收入 (%)8.2136.8696.9997.1586.464

收益指标分析
经营活动净收益/利润总额(%)95.39095.68496.763100.03495.722
价值变动净收益/利润总额(%)4.1974.9542.0800.3662.569
营业外收支净额/利润总额(%)-0.419-0.979-0.844-0.429-0.072

偿债能力分析
流动比率 (X)1.3121.2591.0761.0951.174
速动比率 (X)0.9500.8990.7380.7210.723
资产负债率 (%)57.19859.27256.71756.65253.879
带息债务/全部投入资本 (%)43.81644.67039.31638.39433.575
股东权益/带息债务 (%)107.343101.354125.160129.685154.859
股东权益/负债合计 (%)70.37764.68671.62071.77181.429
利息保障倍数 (X)16.68813.55024.64218.91312.647

营运能力分析
应收账款周转天数 (天)29.62231.88431.73326.43822.399
存货周转天数 (天)110.413104.14195.72299.615102.627